...
首页> 外文期刊>International Journal of Pharmaceutics >PLA-microparticles formulated by means a thermoreversible gel able to modify protein encapsulation and release without being co-encapsulated.
【24h】

PLA-microparticles formulated by means a thermoreversible gel able to modify protein encapsulation and release without being co-encapsulated.

机译:通过热可逆凝胶配制的PLA微粒能够修饰蛋白质的包裹和释放,而不会被共包裹。

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this work was to develop a novel strategy for the formulation of biodegradable PLA microspheres as delivery systems for proteins or peptides. The strategy is based on the exploitation of the gel-sol transition of the thermoreversible Pluronic F127 gel. The gel allows the formation of the particles without be co-entrapped in the matrix. The microspheres prepared using the novel technique (TG-Ms, or thermoreversible gel-method microspheres) were characterized in vitro (as concerns the size, the morphology, the protein encapsulation, the release and the protein distribution in the polymer matrix), in comparison with microspheres prepared using the classical double emulsion/solvent evaporation method (w/o/w-Ms). Two types of bovine serum albumin (BSA), with different water solubility, were used as model proteins. TG-Ms exhibited small size (7-50m) and high protein content (8.6%, w/w) regardless of the BSA water solubility, in contrast with w/o/w-Ms, which revealed a size range of 100-130mum and a protein content related to the BSA water solubility. TG-Ms, in spite of their smaller size respect of the w/o/w-Ms, displayed a reduced initial burst effect and a higher rate in the second release phase that resulted in a quasi-constant profile. The release behavior of the TG-Ms may be attributable to both the localization of the protein in the particle core, as shown by the confocal laser scanning microscopy analysis on labeled-BSA loaded microspheres, and the few pores in the matrix, as shown by the scanning electron microscopy. A working hypothesis about the mechanism of the particle formation was also discussed.
机译:这项工作的目的是为将可生物降解的PLA微球配制成蛋白质或肽的输送系统开发一种新的策略。该策略基于对热可逆Pluronic F127凝胶的凝胶-溶胶转变的利用。凝胶允许形成颗粒而不会被共包裹在基质中。相比之下,使用新技术制备的微球(TG-Ms或热可逆凝胶法微球)在体外进行了表征(关于大小,形态,蛋白质包封,聚合物基质中的释放和蛋白质分布)用经典的双乳液/溶剂蒸发法(w / o / w-Ms)制备的微球。两种水溶性不同的牛血清白蛋白(BSA)被用作模型蛋白。 TG-Ms的体积小(7-50m)和蛋白质含量高(8.6%,w / w),与BSA的水溶性无关,而w / o / w-Ms的大小范围为100-130mum以及与BSA水溶性相关的蛋白质含量。 TG-M尽管相对于w / o / w-Ms具有较小的尺寸,但在第二释放阶段显示出降低的初始爆发效应和较高的速率,从而导致了准恒定的分布。 TG-Ms的释放行为可能归因于蛋白质在颗粒核中的定位(如对标记的BSA负载的微球的共聚焦激光扫描显微镜分析所显示的)以及基质中的孔少(如扫描电子显微镜。还讨论了有关颗粒形成机理的可行假设。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号